FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new derivatives of tetrahydropyridine of the formula (I): wherein (a) means unsubstituted phenyl group or phenyl group substituted with 1, 2 or 3 substitutes chosen independently among (C1-C4)-alkoxy-group, or (b) means unsubstituted indolyl group; R1 and R2 are similar or different and mean hydrogen atom, (C1-C4)-alkyl or phenyl group; X means alkylene group with a direct chain comprising 5, 6, 7 carbon atoms, and to their pharmaceutically acceptable salts also. Also, invention relates to a pharmaceutical composition possessing the inhibitory activity with respect to HDAC based on these compounds. Invention provides new compounds and pharmaceutical composition based on thereof for aims the stimulation of anti-proliferative effect in warm-blooded animals, such as humans.
EFFECT: valuable medicinal properties of compounds and composition.
4 cl, 1 tbl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF TETRALONE AS ANTITUMOR AGENTS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2288220C2 |
DERIVATIVES OF TETRAHYDROISOQUINOLYLACETAMIDE AS OREXIN RECEPTOR ANTAGONISTS | 2004 |
|
RU2345985C2 |
DERIVATIVES OF QUINOLINE XANTHINE AND 8-ISOQUINOLINE XANTHINE AS INHIBITORS OF PHOSPHODIESTERASE PDE-5 | 2001 |
|
RU2269529C2 |
DERIVATIVES OF ANTHRANILIC ACID, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1997 |
|
RU2195454C2 |
COMPOUNDS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2004 |
|
RU2317985C1 |
DERIVATIVES OF NOSCAPINE (VARIANTS), COMBINATORY AND FOCUSED LIBRARIES, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2304584C1 |
2,3,4,9-TETRAHYDRO-1H-CARBAZOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2404163C2 |
SUBSTITUTED DERIVATIVES OF 1, 2, 3, 4-TETRAHYDROISOQUINOLINE | 2005 |
|
RU2378257C2 |
GLUTAMINE FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE INHIBITORS | 2004 |
|
RU2355686C2 |
DERIVATIVES OF BETA-CARBOLINE POSSESSING EFFECT OF PHOSPHODIESTERASE INHIBITORS, PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ITS PREPARING, METHOD FOR INHIBITION OF PHOSPHODIESTERASE EFFECT (VARIANTS) AND METHOD FOR INCREASING CGMP CONCENTRATION | 2001 |
|
RU2271358C2 |
Authors
Dates
2006-05-10—Published
2001-12-21—Filed